{"id":"https://openalex.org/W2414616571","doi":null,"title":"The use of chemically modified cyclodextrins in the development of formulations for chemical delivery systems.","display_name":"The use of chemically modified cyclodextrins in the development of formulations for chemical delivery systems.","publication_year":2002,"publication_date":"2002-02-01","ids":{"openalex":"https://openalex.org/W2414616571","mag":"2414616571","pmid":"https://pubmed.ncbi.nlm.nih.gov/11878196"},"language":"en","primary_location":{"id":"pmid:11878196","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11878196","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Die Pharmazie","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109081047","display_name":"Marcus Eli Brewster","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"M E Brewster","raw_affiliation_strings":["Department of Drug Delivery Research, Division of Chem-Pharm Drug Evaluation, Janssen Research Foundation, Beerse, Belgium. mbrewste@janbe.jnj.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Delivery Research, Division of Chem-Pharm Drug Evaluation, Janssen Research Foundation, Beerse, Belgium. mbrewste@janbe.jnj.com","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062520026","display_name":"\u00deorsteinn Loftsson","orcid":"https://orcid.org/0000-0002-9439-1553","observed_orcids":["https://orcid.org/0000-0002-9439-1553"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T Loftsson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.8433,"has_fulltext":false,"cited_by_count":46,"citation_normalized_percentile":{"value":0.81414291,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"57","issue":"2","first_page":"94","last_page":"101"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.007000000216066837,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chemically-modified-cyclodextrins","display_name":"chemically modified cyclodextrins","score":0.9829999804496765},{"id":"https://openalex.org/keywords/hydroxypropyl-beta-cyclodextrin","display_name":"hydroxypropyl-\u03b2-cyclodextrin","score":0.9950000047683716},{"id":"https://openalex.org/keywords/chemical-delivery-systems","display_name":"chemical delivery systems","score":0.7850000262260437},{"id":"https://openalex.org/keywords/drug-delivery-to-the-brain","display_name":"brain drug delivery","score":0.8700000047683716},{"id":"https://openalex.org/keywords/drug-solubilization","display_name":"drug solubilization","score":0.7059999704360962},{"id":"https://openalex.org/keywords/parenteral-administration","display_name":"parenteral administration","score":0.6320000290870667},{"id":"https://openalex.org/keywords/estradiol","display_name":"estradiol","score":0.7020000219345093},{"id":"https://openalex.org/keywords/zidovudine","display_name":"zidovudine","score":1.0},{"id":"https://openalex.org/keywords/dexamethasone","display_name":"dexamethasone","score":0.9990000128746033}],"concepts":[{"id":"https://openalex.org/C2777239854","wikidata":"https://www.wikidata.org/wiki/Q902638","display_name":"Excipient","level":2,"score":0.7169393301010132},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6943639516830444},{"id":"https://openalex.org/C155574463","wikidata":"https://www.wikidata.org/wiki/Q170731","display_name":"Solubility","level":2,"score":0.6590312719345093},{"id":"https://openalex.org/C77281830","wikidata":"https://www.wikidata.org/wiki/Q718608","display_name":"Dosage form","level":2,"score":0.6285476684570312},{"id":"https://openalex.org/C2910962261","wikidata":"https://www.wikidata.org/wiki/Q40417805","display_name":"Beta-Cyclodextrins","level":3,"score":0.6100780367851257},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.5772507786750793},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5449605584144592},{"id":"https://openalex.org/C2779433975","wikidata":"https://www.wikidata.org/wiki/Q40417805","display_name":"Cyclodextrin","level":2,"score":0.544883668422699},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.544842541217804},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.439378023147583},{"id":"https://openalex.org/C45904493","wikidata":"https://www.wikidata.org/wiki/Q912807","display_name":"Active ingredient","level":2,"score":0.4342171549797058},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.25975194573402405},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.2577284276485443},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.13706177473068237}],"mesh":[{"descriptor_ui":"D003505","descriptor_name":"Cyclodextrins","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D005079","descriptor_name":"Excipients","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:11878196","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11878196","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Die Pharmazie","raw_type":"Journal Article"},{"id":"mag:2414616571","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11878196","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8560000061988831,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4416192812","https://openalex.org/W2068987609","https://openalex.org/W2398797418","https://openalex.org/W3007003667","https://openalex.org/W7163790682","https://openalex.org/W2054159161","https://openalex.org/W7116960782","https://openalex.org/W2159559326","https://openalex.org/W7204991087","https://openalex.org/W4293169353"],"abstract_inverted_index":{"Retrometabolic":[0],"drug":[1,13],"design":[2],"provides":[3],"a":[4,72,90,117,138,150],"highly":[5],"useful":[6,60],"and":[7,33,53,101,108,124,134,149,167],"directed":[8],"approach":[9],"for":[10,37,47,165,172],"identifying":[11],"new":[12],"candidates":[14],"with":[15,82],"improved":[16,106],"therapeutic":[17],"indices":[18],"based":[19,43,153],"on":[20,44,154],"predictable/controlled":[21],"metabolism":[22],"and/or":[23],"site-targeted":[24],"delivery.":[25],"In":[26,158],"the":[27,45,122,132],"process,":[28],"formulation":[29],"becomes":[30],"an":[31,155],"important":[32],"integral":[34],"concern":[35],"especially":[36],"brain-targeting":[38],"chemical":[39],"delivery":[40],"systems":[41],"(CDS)":[42],"need":[46],"appropriate":[48],"dosage":[49,169],"form":[50],"stability,":[51],"solubility":[52,100],"dissolution":[54],"characteristics.":[55],"Adjuncts":[56],"that":[57],"have":[58],"been":[59],"in":[61,89,116,121],"this":[62],"regard":[63],"are":[64],"chemically":[65],"modified,":[66],"water":[67,99],"soluble":[68],"cyclodextrin":[69,113],"derivatives":[70],"such":[71],"2-hydroxypropyl-beta-cyclodextrin":[73],"(HP":[74],"beta":[75,127,162],"CD).":[76],"These":[77],"starch-derived":[78],"excipients":[79],"can":[80],"interact":[81],"drugs":[83],"via":[84],"dynamic":[85],"complex":[86],"formation":[87],"resulting":[88],"number":[91,118,139],"of":[92,119,137,140],"beneficial":[93],"pharmaceutical":[94],"effects":[95],"including":[96,142],"increased":[97],"apparent":[98],"stability":[102],"as":[103,105],"well":[104],"aesthetic":[107],"excipient":[109],"compatibility":[110],"properties.":[111],"This":[112],"is":[114],"approved":[115],"product":[120],"US":[123],"world-wide.":[125],"HP":[126,161],"CD":[128,163],"has":[129],"contributed":[130],"to":[131],"development":[133],"preclinical/clinical":[135],"testing":[136],"CDS":[141,152],"E2":[143],"(estradiol)-CDS,":[144],"AZT":[145],"(zidovudine)-CDS,":[146],"DEX":[147],"(dexamethasone)-CDS":[148],"neuropeptide":[151],"enkephalin":[156],"derivative.":[157],"these":[159],"contexts,":[160],"provided":[164],"stable":[166],"water-soluble":[168],"forms":[170],"intended":[171],"parenteral":[173],"administration.":[174]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}